Morgan Stanley
CANO

Morgan Stanley’s Cano Health, Inc. CANO Stock Holding History

Morgan Stanley’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,493
Closed -$150K – 8128
2023
Q4 		$150K Buy
25,493
+21,091
+479% +$250K ﹤0.01% 5794
2023
Q3 		$112K Sell
4,402
-3,665
-45% -$301K ﹤0.01% 5846
2023
Q2 		$1.12M Sell
8,067
-596
-7% -$76.5K ﹤0.01% 4767
2023
Q1 		$788K Sell
8,663
-42,164
-83% -$5.72M ﹤0.01% 4996
2022
Q4 		$6.96M Buy
50,827
+41,787
+462% +$14.1M ﹤0.01% 3441
2022
Q3 		$7.84M Buy
9,040
+1,085
+14% +$680K ﹤0.01% 3222
2022
Q2 		$3.48M Sell
7,955
-265
-3% -$138K ﹤0.01% 4085
2022
Q1 		$5.22M Buy
8,220
+2,323
+39% +$1.46M ﹤0.01% 3644
2021
Q4 		$5.25M Buy
5,897
+2,474
+72% +$2.6M ﹤0.01% 3667
2021
Q3 		$4.34M Buy
3,423
+2,484
+265% +$3.01M ﹤0.01% 3890
2021
Q2 		$1.14M Buy
939
+890
+1,816% +$1.2M ﹤0.01% 5007
2021
Q1 		$65K Sell
49
-399
-89% -$565K ﹤0.01% 6230
2020
Q4 		$601K Buy
448
+395
+745% +$452K ﹤0.01% 4965
2020
Q3 		$55K Buy
+53
New +$55.4K ﹤0.01% 5694

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Morgan Stanley's CANO Position: Q1 2024 in Review

Morgan Stanley sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 25,493 shares — an estimated $150K sold.

Morgan Stanley first reported a position in CANO in Q3 2020 and held it in 14 quarters. The position peaked at $7.84M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Morgan Stanley reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 25,493 Cano Health, Inc. shares in Q1 2024, an estimated $150K.
  • Morgan Stanley first reported a position in Cano Health, Inc. in Q3 2020 and held it in 14 quarters.
  • Morgan Stanley's Cano Health, Inc. position peaked at $7.84M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.